Copyright Reports & Markets. All rights reserved.

Global Amlodipine Besylate Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Amlodipine Besylate Industry
  • 1.7 COVID-19 Impact: Amlodipine Besylate Market Trends

    • 2 Global Amlodipine Besylate Quarterly Market Size Analysis

    • 2.1 Amlodipine Besylate Business Impact Assessment - COVID-19
      • 2.1.1 Global Amlodipine Besylate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Amlodipine Besylate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Amlodipine Besylate Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Amlodipine Besylate Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Amlodipine Besylate Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Amlodipine Besylate Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Amlodipine Besylate Market
    • 3.5 Key Manufacturers Amlodipine Besylate Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Amlodipine Besylate Segments, By Type

    • 4.1 Introduction
      • 1.4.1 2.5mg Tablets
      • 1.4.2 5mg Tablets
      • 1.4.3 10mg Tablets
    • 4.2 By Type, Global Amlodipine Besylate Market Size, 2019-2021
      • 4.2.1 By Type, Global Amlodipine Besylate Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Amlodipine Besylate Price, 2020-2021

    5 Impact of Covid-19 on Amlodipine Besylate Segments, By Application

    • 5.1 Overview
      • 5.5.1 High Blood Pressure
      • 5.5.2 Heart Disease
    • 5.2 By Application, Global Amlodipine Besylate Market Size, 2019-2021
      • 5.2.1 By Application, Global Amlodipine Besylate Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Amlodipine Besylate Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Pfizer
      • 7.1.1 Pfizer Business Overview
      • 7.1.2 Pfizer Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.1.3 Pfizer Amlodipine Besylate Product Introduction
      • 7.1.4 Pfizer Response to COVID-19 and Related Developments
    • 7.2 Mylan
      • 7.2.1 Mylan Business Overview
      • 7.2.2 Mylan Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.2.3 Mylan Amlodipine Besylate Product Introduction
      • 7.2.4 Mylan Response to COVID-19 and Related Developments
    • 7.3 Dr. Reddy's Laboratories
      • 7.3.1 Dr. Reddy's Laboratories Business Overview
      • 7.3.2 Dr. Reddy's Laboratories Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Product Introduction
      • 7.3.4 Dr. Reddy's Laboratories Response to COVID-19 and Related Developments
    • 7.4 Apotex
      • 7.4.1 Apotex Business Overview
      • 7.4.2 Apotex Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.4.3 Apotex Amlodipine Besylate Product Introduction
      • 7.4.4 Apotex Response to COVID-19 and Related Developments
    • 7.5 Teva Pharmaceutical
      • 7.5.1 Teva Pharmaceutical Business Overview
      • 7.5.2 Teva Pharmaceutical Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.5.3 Teva Pharmaceutical Amlodipine Besylate Product Introduction
      • 7.5.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
    • 7.6 Cipla
      • 7.6.1 Cipla Business Overview
      • 7.6.2 Cipla Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.6.3 Cipla Amlodipine Besylate Product Introduction
      • 7.6.4 Cipla Response to COVID-19 and Related Developments
    • 7.7 Hikma Pharmaceuticals
      • 7.7.1 Hikma Pharmaceuticals Business Overview
      • 7.7.2 Hikma Pharmaceuticals Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.7.3 Hikma Pharmaceuticals Amlodipine Besylate Product Introduction
      • 7.7.4 Hikma Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.8 Strides Pharma
      • 7.8.1 Strides Pharma Business Overview
      • 7.8.2 Strides Pharma Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.8.3 Strides Pharma Amlodipine Besylate Product Introduction
      • 7.8.4 Strides Pharma Response to COVID-19 and Related Developments
    • 7.9 Upsher-Smith Laboratories
      • 7.9.1 Upsher-Smith Laboratories Business Overview
      • 7.9.2 Upsher-Smith Laboratories Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.9.3 Upsher-Smith Laboratories Amlodipine Besylate Product Introduction
      • 7.9.4 Upsher-Smith Laboratories Response to COVID-19 and Related Developments
    • 7.10 InvaGen Pharmaceuticals
      • 7.10.1 InvaGen Pharmaceuticals Business Overview
      • 7.10.2 InvaGen Pharmaceuticals Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Product Introduction
      • 7.10.4 InvaGen Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.11 Sun Pharmaceutical
      • 7.11.1 Sun Pharmaceutical Business Overview
      • 7.11.2 Sun Pharmaceutical Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.11.3 Sun Pharmaceutical Amlodipine Besylate Product Introduction
      • 7.11.4 Sun Pharmaceutical Response to COVID-19 and Related Developments
    • 7.12 Aurobindo Pharma
      • 7.12.1 Aurobindo Pharma Business Overview
      • 7.12.2 Aurobindo Pharma Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.12.3 Aurobindo Pharma Amlodipine Besylate Product Introduction
      • 7.12.4 Aurobindo Pharma Response to COVID-19 and Related Developments
    • 7.13 Lupin Pharmaceuticals
      • 7.13.1 Lupin Pharmaceuticals Business Overview
      • 7.13.2 Lupin Pharmaceuticals Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.13.3 Lupin Pharmaceuticals Amlodipine Besylate Product Introduction
      • 7.13.4 Lupin Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.14 Zydus Pharmaceuticals
      • 7.14.1 Zydus Pharmaceuticals Business Overview
      • 7.14.2 Zydus Pharmaceuticals Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.14.3 Zydus Pharmaceuticals Amlodipine Besylate Product Introduction
      • 7.14.4 Zydus Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.15 Oxford Pharm
      • 7.15.1 Oxford Pharm Business Overview
      • 7.15.2 Oxford Pharm Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.15.3 Oxford Pharm Amlodipine Besylate Product Introduction
      • 7.15.4 Oxford Pharm Response to COVID-19 and Related Developments
    • 7.16 Wockhardt
      • 7.16.1 Wockhardt Business Overview
      • 7.16.2 Wockhardt Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.16.3 Wockhardt Amlodipine Besylate Product Introduction
      • 7.16.4 Wockhardt Response to COVID-19 and Related Developments
    • 7.17 Epic Pharma
      • 7.17.1 Epic Pharma Business Overview
      • 7.17.2 Epic Pharma Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.17.3 Epic Pharma Amlodipine Besylate Product Introduction
      • 7.17.4 Epic Pharma Response to COVID-19 and Related Developments
    • 7.18 CR Pharmaceutical
      • 7.18.1 CR Pharmaceutical Business Overview
      • 7.18.2 CR Pharmaceutical Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.18.3 CR Pharmaceutical Amlodipine Besylate Product Introduction
      • 7.18.4 CR Pharmaceutical Response to COVID-19 and Related Developments
    • 7.19 Alkem Laboratories
      • 7.19.1 Alkem Laboratories Business Overview
      • 7.19.2 Alkem Laboratories Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.19.3 Alkem Laboratories Amlodipine Besylate Product Introduction
      • 7.19.4 Alkem Laboratories Response to COVID-19 and Related Developments
    • 7.20 MACLEODS
      • 7.20.1 MACLEODS Business Overview
      • 7.20.2 MACLEODS Amlodipine Besylate Quarterly Production and Revenue, 2020
      • 7.20.3 MACLEODS Amlodipine Besylate Product Introduction
      • 7.20.4 MACLEODS Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Amlodipine Besylate Supply Chain Analysis
      • 8.1.1 Amlodipine Besylate Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Amlodipine Besylate Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Amlodipine Besylate Distribution Channels
      • 8.2.2 Covid-19 Impact on Amlodipine Besylate Distribution Channels
      • 8.2.3 Amlodipine Besylate Distributors
    • 8.3 Amlodipine Besylate Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Amlodipine Besylate, including the following market information:
      Global Amlodipine Besylate Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Amlodipine Besylate Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Amlodipine Besylate Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Amlodipine Besylate Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Pfizer, Mylan, Dr. Reddy's Laboratories, Apotex, Teva Pharmaceutical, Cipla, Hikma Pharmaceuticals, Strides Pharma, Upsher-Smith Laboratories, InvaGen Pharmaceuticals, Sun Pharmaceutical, Aurobindo Pharma, Lupin Pharmaceuticals, Zydus Pharmaceuticals, Oxford Pharm, Wockhardt, Epic Pharma, CR Pharmaceutical, Alkem Laboratories, MACLEODS, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      2.5mg Tablets
      5mg Tablets
      10mg Tablets

      Based on the Application:
      High Blood Pressure
      Heart Disease

      Buy now